Clinical Trial Update: A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC [Phase 1, Phase 2]

View source ↗

Summary

This is a first-in-human Phase I/IIa trial assessing the feasibility of Tumor-infiltrating lymphocyte (TIL)–based immunotherapy in patients with metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Prostate Cancer

Drugs mentioned

• Tumor-infiltrating lymphocyte (TIL) therapy

Snippet

Sponsor: Curacell Holding AB | Conditions: Metastatic Colorectal Cancer, Prostate Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING